Clinical trial
A Phase 1/2a Randomized, Double-Blind Placebo-controlled Study of Intra-articular Allocetra in Knee Osteoarthritis
NCT06233474 is registered in ClinicalTrials.gov with Enlivex Therapeutics Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2a Randomized, Double-Blind Placebo-controlled Study of Intra-articular Allocetra in Knee Osteoarthritis
- Lead sponsor
- Enlivex Therapeutics Ltd.
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- January 26, 2024
- Completion date
- May 15, 2026
- Enrollment
- 160 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.